UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 
Apple Turns 50: From Garage Startup to AI Crossroads 
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 
Britain Courts Anthropic Amid US Defense Department Dispute 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal 
FARMINGTON, Conn., Nov. 21, 2016 -- Immuron Limited: According to AAA research released this week, 48.7 million Americans are expected to travel within the U.S. this Thanksgiving. Many will unfortunately get sick, or experience intestinal discomfort, from the food they eat.
And, while most people associate improper sanitation of food and water during international travel with E. coli-based illnesses, last year’s largest ongoing E. coli outbreak was actually in the United States, and took place at several Chipotle restaurants. So it’s important to be prepared when you stop for a quick bite to eat as you travel for your holiday celebrations.
Travelan was developed by Australian bio-pharmaceutical company Immuron Limited to help protect your intestinal track against the 13 most common strains of E. coli*. Popular in its native Australia for the past 10 years, and in Canada for the past three years, Travelan is now available in the United States on CVS.com and in select CVS/pharmacy stores, on Amazon.com, at Passport Health clinics and other travel medical providers.
About Travelan:
- Travelan is a non-prescription dietary supplement uniquely formulated to be high in antibodies that can help support and maintain gastrointestinal and digestive function and health.
- Travelan’s active ingredient is Hyperimmune Bovine Colostrum Powder, which has been specifically engineered to be a rich source of antibodies that bind to Enterotoxigenic E. coli in the gastrointestinal tract, preventing them from attaching to the intestinal wall and thereby neutralizing their ability to cause diarrhea and its associated symptoms.
- Hyperimmune Colostrum was developed with Immuron’s Proprietary Technology to create high titers of antibodies to a range of E-Coli bacteria that is present in normal colostrum in only very small amounts.
About Immuron Limited:
Immuron Limited™ is a publicly listed Australian bio-pharmaceutical company (ASX:IMC) focused on oral immunotherapy using polyclonal antibody products. Immuron is a uniquely positioned company developing therapeutic products in NASH (fatty-liver disease), ASH (alcoholic fatty-liver disease) and other diseases mediated through gut dysbiosis.
Visit www.Immuron.com to learn more about the company or www.TravelanUSA.com to learn more about Travelan.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Media Contact: Kathy Kaschuluk [email protected]
